Name: Retrovir (Zidovudine)
Brand: Retrovir (Zidovudine)
SKU: D-7385
Availability: InStock

Retrovir (Zidovudine)

Author Dev, posted on June 16, 2017

Category:

Retrovir

Zidovudine

Zidovudine (Generic)

Zidovudine

BEFORE you use RETROVIR (AZT) talk to your doctor or pharmacist if:

you are allergic to any ingredient in this medicine.
you have bone marrow problems (low blood cell counts).
you have hepatomegaly (enlarged liver), hepatitis (inflamed liver) or other known risk factors for liver disease.
you have kidney disease.
you are taking other drugs
you are pregnant or breastfeeding.
your baby or infant was exposed to Nucleoside Reverse Transcriptase Inhibitors (NRTIs) during pregnancy or labour.
you are taking ribavirin as it could cause or worsen anemia (symptoms of tiredness, shortness of breath).
Your doctor will advise whether you should stop taking RETROVIR (AZT).

Illness associated with HIV infection, including other infections, may still happen. Therefore, it is very important to keep appointments with your doctor and to report any change in your health as it occurs.

RETROVIR (AZT) has been extensively studied in humans for limited periods of time. Studies have shown that treatment will benefit your health. However, the effectiveness and overall safety of RETROVIR (AZT) is unknown beyond the length of time for which it has been studied.

The effectiveness and overall safety of RETROVIR (AZT) in women, intravenous drug users, and ethnic minorities are not different than that observed in white males.

Solution for Infusion:

The rubber stopper of the RETROVIR (AZT) intravenous vials contains latex. Tell your doctor if you are allergic to latex.

Use of This Medication During Pregnancy and Breast Feeding:

Before you use RETROVIR (AZT), talk to your doctor or pharmacist if you are pregnant, planning to become pregnant, or become pregnant while taking RETROVIR (AZT). It is not known if RETROVIR (AZT) can harm your unborn child. You and your doctor will need to decide if taking RETROVIR (AZT) is right for you. If you take RETROVIR (AZT) while you are pregnant, talk to your doctor about how you can be included in the Antiretroviral Pregnancy Registry.

For pregnant women who are considering the use of RETROVIR (AZT) during pregnancy for the prevention of HIV-transmission to their infants, it is important to understand that transmission may still occur in some cases (about 8%) despite using RETROVIR (AZT). The long-term safety in treated fetuses, neonates, or infants has not been established.

Babies and infants exposed to Nucleoside Reverse Transcriptase Inhibitors (NRTIs) during pregnancy or labour, show minor temporary increases in blood levels of lactate. The clinical importance of these temporary increases is unknown.

There have been very rare reports of diseases that affect the nervous system such as delayed development and seizures.

These findings do not affect current recommendations to use antiretroviral therapy in pregnant women to prevent transmission of HIV to their babies.

HIV-infected women should not breast-feed in order to prevent transmission of HIV to a child who may not yet be infected. The ingredients in RETROVIR (AZT) can also pass into your breast-milk.

Side-effects of RETROVIR (AZT) include nausea, vomiting, fever, headache, stomach pain, loss of appetite, muscle pain, low white blood cell count (neutropenia or leucopenia), decrease in the number of cells involved in blood clotting (thrombocytopenia) or in all kinds of blood cells (pancytopenia), reduction in the number of red blood cells (pure red cell aplasia), failure of the bone marrow to produce new blood cells (aplastic anaemia), an increase in lactic acid, feeling depressed or anxious, dizziness, not being able to sleep, tingly feelings in the skin (pins and needles), not being able to concentrate, feeling drowsy, seizures, disease of the heart muscle, cough, intestinal gas, changes in the colour of the nails, skin, or the skin inside the mouth, taste disturbance, indigestion, skin rash (red, raised or itchy skin), sweating, passing urine more often, enlarged breasts in men, general aches and pain, chills, chest pain, flu-like feeling. If these become bothersome, consult your doctor.

Changes in your immune system (Immune Reconstitution Syndrome) can happen when you start taking HIV medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time, or you could develop an autoimmune disease in which your immune system reacts against your own body (e.g. Graves' disease (which affects the thyroid gland), Guillain-Barré syndrome (which affects the nervous system) or polymyositis (which affects the muscles) and it may develop at any time, sometimes months later after the start of HIV therapy). Sometimes symptoms can be severe, so if you develop high temperature (fever), joint or muscle pain, redness, rash, swelling, or fatigue or any new symptoms contact your doctor straight away.

An important but reversible side-effect of RETROVIR (AZT), particularly in patients with more severe disease, can be a decrease in certain types of blood counts (including red blood cells, white blood cells and platelets) and increase in certain liver enzymes. Since a reduction in these cells can directly affect your health, it is important to have your blood tested as often as your doctor requests it. In some cases, it may be necessary to adjust the dose of the drug, temporarily discontinue the drug, give a blood transfusion, or stop the drug altogether.

It is important to understand that although these blood effects can occur at any stage, they are much more common in advanced disease and in patients who start RETROVIR (AZT) therapy late in their illness.

Contact your doctor if you experience muscle weakness, shortness of breath, symptoms of hepatitis or pancreatitis (which include very severe stomach cramps) or any other unexpected adverse events while being treated with RETROVIR (AZT).

This is not a complete list of side effects. For any unexpected effects while taking RETROVIR (AZT), contact your doctor or pharmacist.

Some drugs may change the usefulness and safety of RETROVIR (AZT). It is therefore very important that you tell your doctor before you decide to take any new drugs, even if these are available without a prescription.

Drugs that may interact with RETROVIR (AZT) include: atovaquone, bone marrow suppressive agents/cytotoxic agents, clarithromycin, fluconazole, ganciclovir, interferon-alpha, lamivudine, methadone, phenytoin, probenecid, stavudine, valproic acid, and others such as trimethoprim-sulfamethoxazole, pyrimethamine, acyclovir and rifampin.

For patients receiving combination therapy with RETROVIR (AZT) and zalcitabine, it is important to understand that the major toxicity of zalcitabine is peripheral neuropathy. Pancreatitis is another serious and potentially life-threatening toxicity that has been reported in less than 1% of patients treated with zalcitabine alone. Symptoms of peripheral neuropathy include tingling, burning, pain, or numbness in the hands or feet. Symptoms of pancreatitis include abdominal pain, nausea and vomiting. These symptoms should be promptly reported to your physician. Since the development of peripheral neuropathy seems to be dose-related to zalcitabine, you should follow your physician's instructions regarding the prescribed dose. The long-term effects of zalcitabine in combination with RETROVIR (AZT) are presently unknown. If you are a female of child-bearing age, you should use effective contraception while using zalcitabine.

An additional precaution is that some other drugs may change the usefulness and safety of RETROVIR (AZT).

Usual dose:

You should be counselled about the use of RETROVIR (AZT).

It is important to take RETROVIR (AZT) exactly as prescribed. Altering the dose without the direct advice of your physician is unwise, as is sharing your medication with others.

Oral Administration:

Adults and Adolescents 30 kg and Over:

The recommended total oral daily dose of RETROVIR (AZT) is 600 mg per day in divided doses in combination with other antiretroviral agents. Suggested Dosing Regimens:

Capsules: three 100 mg RETROVIR (AZT) capsules every 12 hours; OR two 100 mg RETROVIR (AZT) capsules every 8 hours.
Syrup: 6 teaspoonfuls (30 mL) RETROVIR (AZT) syrup every 12 hours; OR 4 teaspoonfuls (20 mL) RETROVIR (AZT) syrup every 8 hours.

Children (≥4 kg):

The recommended oral dose in children weighing ≥4 kg

Children should be assessed for the ability to swallow capsules. If a child has difficulty in swallowing a RETROVIR (AZT) capsule, the RETROVIR (AZT) syrup formulation should be prescribed.

RETROVIR (AZT) Syrup is available for dosing children who weigh less than 30 kg. RETROVIR (AZT) Syrup should be used to provide accurate dosage when capsules are not appropriate.

Alternatively, dosing for RETROVIR can be based on body surface area (BSA) for each child. The usual dose of RETROVIR is 480 mg/m2per day, divided equally into two or three doses per day. In some cases the dose calculated by mg for each kg will not be the same as that calculated by BSA.

Children (<4 kg):

Available data are insufficient to propose specific dosing recommendations for children weighing <4 kg.

Solution for Infusion:

Adults and Adolescents 30 kg and Over:

The recommended dose is 1 to 2 mg/kg administered as a 1 hour infusion every 4 hours around the clock (6 times daily). RETROVIR (AZT) solution for infusion is administered intravenously at a constant rate over 1 hour. Rapid infusion or bolus injection should be avoided. RETROVIR (AZT) solution for infusion should not be given intramuscularly.

If you are also taking clarithromycin, your doctor may advise you to take this medication at least 2 hours before or 2 hours after RETROVIR(AZT), to avoid a drug interaction.

Children:

The recommended dose of RETROVIR (AZT) I.V. Injection in children 3 months to 12 years of age is 120 mg/m2 every 6 hours, infused over 1 hour (480 mg/m2 per day). Do not exceed 160 mg for any individual dose.

Prevention of Maternal-Fetal HIV Transmission:

The recommended dosing regimen for administration to pregnant women (>14 weeks of pregnancy) and their newborn infant is:

Maternal Dosing: 100 mg orally 5 times per day until the start of labour. During labour and delivery, intravenous RETROVIR (AZT) should be administered at 2 mg/kg (total body weight) over 1 hour followed by a continuous intravenous infusion at 1 mg/kg/h (total body weight) until clamping of the umbilical cord.
Infant Dosing: 2 mg/kg of oral solution every 6 hours starting within 12 hours after birth and continuing through 6 weeks of age. Infants unable to receive oral dosing may be administered RETROVIR (AZT) intravenously at 1.5 mg/kg, infused over 30 minutes, every 6 hours.

Overdose:

If you are concerned that you may have taken too much RETROVIR, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Genvoya (Tenofovir Alafenamide, Elvitegravir, Cobicistat, Emtricitabine)

Author Dev, posted on June 16, 2017

Category:

Genvoya

Emtricitabine, Cobicistat, Elvitegravir, Tenofovir Alafenamide

Genvoya

Emtricitabine, Cobicistat, Elvitegravir, Tenofovir Alafenamide

Genvoya

Emtricitabine, Cobicistat, Elvitegravir, Tenofovir Alafenamide

Genvoya (Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide) Medication Information

Uses

Genvoya is an antiviral combination medication that is used to treat human immunosuppressant virus (HIV)

Dosage

The tablets are available in 150-150-200-10 mg strength.

Side Effects

The most common side effects of Genvoya include:

Nausea
Diarrhea
Fatigue
Headache

Speak with your doctor for a full list of side effects that apply to you if you are taking Genvoya.

Precautions

There is a risk of redistribution/accumulation of fat when taking Genvoya.

There is a risk of immune reconstitution with Genvoya, so patients can experience flu like symptoms when starting treatment.

There is a risk of worsening of kidney function with Genvoya.

Interactions

The most common drug interactions with Genvoya include:

Ketoconazole
Clarithromycin
Phenytoin
Phenobarbital
Carbamazepine
SSRIs
SNRIs

Speak with your doctor for more information and before starting a new medication with Genvoya.

Storage

Store below 86 ºF. Genvoya should be dispensed in the original container.

Pharmacist Tips

Taking Genvoya every day is very important to ensure the virus does not build a tolerance to the medication.
Genvoya can cause kidney injury so your kidneys should be monitored.
There is a risk of fat accumulation with Genvoya.

Genvoya FAQs

What are the side effects of Genvoya?

The most common side effects of Genvoya are nausea, diarrhea, fatigue, and headache.

Should Genvoya be taken with food?

Genvoya should be take with food to help the body absorb the medication.

What is Genvoya used to treat?

Genvoya is used to treat HIV

What happens if I stop taking Genvoya?

Stopping Genvoya without doctor approval can result in a resurgence of HIV virus, which can make you very sick, and make it easier to pass the virus to others.

Can Genvoya cause weight gain?

Genvoya does not typically cause weight gain.

Related Drugs

Reference:

Genvoya {package insert}. Foster City, CA: Gilead Science, Inc.; 2016.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207561s002lbl.pdf

Daliresp (Roflumilast)

Author Dev, posted on June 16, 2017

Category:

Daxas

Roflumilast

Daxas

Roflumilast

You should not use DALIRESP if you have moderate or severe liver disease. You should not use DALIRESP if you are allergic to it, or if you have moderate or severe liver disease.

To make sure you can safely take DALIRESP , tell your doctor if you have any of these other conditions:

liver disease;
a history of depression, mental illness, or suicidal thoughts or actions.

You may have unusual thoughts or behavior, or thoughts about suicide, while taking this medicine. Tell your doctor if you have new or worsening depression, or suicidal thoughts. Your family or other caregivers should also be alert to changes in your mood or symptoms.

FDA pregnancy category C. It is not known whether DALIRESP will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. DALIRESP can pass into breast milk and may harm a nursing baby. You should not breast-feed while using this medicine.

Do not give this medication to anyone under 18 years old without medical advice. Do not share this medication with other people, even if they have the same symptoms you have.

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Report any new or worsening symptoms to your doctor, such as: mood or behavior changes, anxiety, depression, trouble sleeping, or if you feel impulsive, or you have thoughts about suicide or hurting yourself.

Call your doctor at once if you have:

rapid and unintended weight loss;
tremors;
pain or burning when you urinate;

Common side effects may include:

nausea, diarrhea;
loss of appetite, minor weight loss;
headache, dizziness;
occasional sleep problems;
back pain; or
flu symptoms.

Viramune XR (Nevirapine)

Author Dev, posted on June 16, 2017

Category:

Viramune XR

Nevirapine

Nevirapine XR (Generic)

Nevirapine

Severe, life-threatening, and in some cases fatal liver toxicity, particularly in the first 18 weeks, has been reported in patients treated with VIRAMUNE, including pregnant women receiving chronic VIRAMUNE therapy in conjunction with other antiretroviral medication. Female gender and higher CD4 counts at the start of therapy may increase the risk of liver problems.

Severe skin and allergic reactions, including fatal cases have occurred with accompanying symptoms such as severe rash with fever, fatigue, muscle/joint pain, swelling of the face, hepatitis (liver inflammation), blood and kidney problems. If this occurs discontinue VIRAMUNE or VIRAMUNE XR and contact your doctor immediately.

In rare cases liver problems have led to liver failure and can lead to a liver transplant or death. Therefore, if you develop any of the following symptoms of liver problems stop taking VIRAMUNE or VIRAMUNE XR and call your doctor right away:

general ill feeling or “flu-like” symptoms
tiredness
nausea (feeling sick to your stomach)
lack of appetite
yellowing skin or whites of your eyes
dark urine (tea colored)
pale stools (bowel movements)
pain, ache, or sensitivity to touch on your right side below your ribs

Your doctor should check you and do blood tests often to check your liver function during the first 18 weeks of therapy. Checks for liver problems should continue regularly during treatment with VIRAMUNE or VIRAMUNE XR.

Skin Reactions:

Skin rash is the most common side effect of VIRAMUNE or VIRAMUNE XR. Most rashes occur in the first 6 weeks of treatment. In a small number of patients, rash can be serious and result in death. Therefore, if you develop a rash with any of the following symptoms, stop using VIRAMUNE or VIRAMUNE XR and call your doctor right away:

general ill feeling or “flu-like” symptoms
fever
muscle or joint aches
conjunctivitis (red or inflamed eyes, like “pinkeye”)
blisters
mouth sores
swelling of your face
tiredness
any symptoms of liver problems discussed above

If your doctor tells you to stop treatment with VIRAMUNE or VIRAMUNE XR because you have experienced the serious liver or skin reactions described above, never take VIRAMUNE or VIRAMUNE XR again.

These are not all the side effects of VIRAMUNE or VIRAMUNE XR. Tell your doctor if you have any side effects from VIRAMUNE or VIRAMUNE XR.

BEFORE you use VIRAMUNE or VIRAMUNE XR talk to your doctor or pharmacist:

If you have or have had any diseases of the liver particularly hepatitis B or C infection;
If you are pregnant or intend to become pregnant;
If you are a breast-feeding mother. It is recommended that HIV infected women not breastfeed, to avoid transmission of the virus to the infant;
If you are taking any medications, including prescription, non-prescription, herbal or homeopathic remedies;
If you have any allergies to foods or drugs;
If you are undergoing dialysis.

VIRAMUNE or VIRAMUNE XR can cause serious liver damage and skin reactions that can cause death. Any patients can experience such side effects, but some patients are more at risk than others.

Other common side effects of VIRAMUNE or VIRAMUNE XR include nausea, fatigue, fever, headache, vomiting, diarrhea, abdominal pain, skin rash and itching, myalgia (muscle pain) and arthralgia (joint pain). This list of side effects is not complete. Ask your doctor or pharmacist for more information.

Abnormal liver function test results, decrease in red blood cells or white blood cells called granulocytes, decrease in blood phosphorus, increase in blood pressure and hypersensitivity including severe allergic reaction with facial swelling may also occur.

If you feel unwell in any other way or have any symptoms that you do not understand, you should contact your doctor immediately.

Sleepiness can occur. Do not drive or operate machinery if you become drowsy.

Always tell your doctor or pharmacist about any undesirable effects you experience after taking VIRAMUNE or VIRAMUNE XR, even those not mentioned above.

Changes in body fat have been seen in some patients taking anti-retroviral therapy. These changes may include increased amount of fat in the upper back and neck (“buffalo hump”), breast, and around the trunk. Loss of fat from the legs, arms and face may also happen. The cause and long term health effects of these conditions are not known at this time.

Occasionally, the inactive ingredients of VIRAMUNE XR extended release tablets may be eliminated in the stool as a soft hydrated mass that looks like a whole tablet. There is no cause for alarm.

Consult your doctor immediately if you experience any symptoms as listed above, or any symptoms that you do not understand.

This is not a complete list of side effects. For any unexpected effects while taking VIRAMUNE or VIRAMUNE XR, contact your doctor or pharmacist.

Drugs that may interact with VIRAMUNE or VIRAMUNE XR include:

VIRAMUNE or VIRAMUNE XR may change the effect of other medicines, and other medicines can change the effect of VIRAMUNE or VIRAMUNE XR. Tell your doctors and pharmacists about all medicines you take, including non-prescription medicines, vitamins and herbal supplements.

Do not take ketoconazole, rifampin, efavirenz, delavirdine, etravirine, rilpivirine, elvitegravir (in combination with cobicistat), or boceprevir; with VIRAMUNE or VIRAMUNE XR.

Tell your doctor if you take clarithromycin, fluconazole, methadone, rifabutin, indinavir, lopinavir/ritonavir combination, saquinavir or itraconazole.

VIRAMUNE or VIRAMUNE XR may not be right for you, or you may need careful monitoring.

You should be aware that VIRAMUNE or VIRAMUNE XR may change the effectiveness of oral contraceptives. Therefore oral contraceptives and other hormonal methods of birth control should not be used as a method of contraception in women taking VIRAMUNE or VIRAMUNE XR; other methods (barrier) must be used.

Usual dose:

Adult:

Follow the directions exactly as given to you by your doctor or pharmacist regarding the amount and frequency of dosing. The label will usually tell you this information as well. If you are not sure about dosing, ask your doctor or pharmacist.

VIRAMUNE Immediate Release Tablets:

As a general guide, swallow one tablet (200 mg) once a day for the first 14 days (this lead-in period should be used because it has been found to lessen the frequency of rash) followed by one 200 mg tablet twice daily as part of a multi-drug treatment program. VIRAMUNE immediate release tablets can be taken with or without food.

VIRAMUNE XR Extended Release Tablets:

Swallow one 200 mg tablet of VIRAMUNE immediate release once daily for the first 14 days to lessen the frequency of rash followed by one 400 mg tablet of VIRAMUNE XR extended release once daily. The VIRAMUNE XR extended release tablets should not be broken or chewed. VIRAMUNE XR extended release tablets can be taken with or without food.

It is important to strictly follow the once daily dose for the first 14 days. Do not start taking the 200 mg VIRAMUNE twice daily or the 400 mg VIRAMUNE XR once daily if you have any symptoms of liver problems or skin rash. The manufacturer's recommended dosage and monitoring for the other administered anti-retroviral drugs should be followed.

Patients Switching to VIRAMUNE XR Extended Release Tablets:

Patients already on a regimen of VIRAMUNE immediate release 200 mg twice daily in combination with other antiretroviral agents can be switched to VIRAMUNE XR extended release 400 mg once daily in combination with other antiretroviral agents without a lead-in period of VIRAMUNE immediate release.

Overdose:

In case of drug overdosage, contact a healthcare practitioner (e.g. doctor), hospital emergency department or regional Poison Control Centre, even if there are no symptoms.

Missed Dose:

If you miss a dose: If you forget to take your medicine, take it as soon as you remember. Then continue as before; do not double your next dosage.

If it is almost time for your next dose, do not take the missed dose. Instead, follow your regular dosing schedule by taking the next dose at its regular time.

If you stop taking VIRAMUNE or VIRAMUNE XR for more than 7 days, ask your doctor how much to take before you start taking it again. You may need to start with once-a-day 200 mg VIRAMUNE tablet dosing.

Avoid doing things that can spread HIV infection, as VIRAMUNE or VIRAMUNE XR does not stop you from passing HIV infection to others. Do not share needles, other injection equipment or personal items that can have blood or body fluids on them, like toothbrushes and razor blades. Always practice safe sex by using a latex or polyurethane condom to lower the chance of sexual contact with semen, vaginal secretions, or blood.

This medicine is for you. Never give it to someone else, as it may harm them even if their symptoms are the same as yours.

Take your medications exactly as prescribed by your doctor. Do not change the dose without consulting your doctor.

Do not take any other medication including prescription, non prescription, herbal or homeopathic remedies without your doctor's advice. Also, inform any other doctor, dentist or pharmacist you consult that you are taking this medication.

Keep out of reach of children.

If you have any other questions about VIRAMUNE or VIRAMUNE XR, contact your doctor or pharmacist.

Viracept (Nelfinavir)

Author Dev, posted on June 16, 2017

Category:

Viracept

Nelfinavir Mesylate

You should not use VIRACEPT if you have moderate to severe liver disease.

Serious drug interactions can occur when certain medicines are used together with VIRACEPT. Tell each of your healthcare providers about all medicines you use now, and any medicine you start or stop using.

You should not take this medication if you are allergic to VIRACEPT, or if you have moderate or severe liver disease.

Some medicines can cause unwanted or dangerous effects when used with VIRACEPT. Your doctor may need to change your treatment plan if you use any of the following drugs:

alfuzosin;
pimozide;
rifampin;
sildenafil (Revatio for pulmonary arterial hypertension);
St. John's wort;
lovastatin or simvastatin;
dihydroergotamine, ergotamine, ergonovine, or methylergonovine;
amiodarone or quinidine; or
oral midazolam, or triazolam.

To make sure VIRACEPT is safe for you, tell your doctor if you have:

liver disease;
kidney disease;
diabetes;
a bleeding disorder such as hemophilia; or
high cholesterol or triglycerides.

This medication is not expected to be harmful to an unborn baby, but HIV can be passed to your baby if you are not properly treated during pregnancy. Tell your doctor if you are pregnant or plan to become pregnant. Take all of your HIV medicines as directed to control your infection.

If you are pregnant, your name may be listed on a pregnancy registry. This is to track the outcome of the pregnancy and to evaluate any effects of VIRACEPT on the baby.

VIRACEPT can make birth control pills less effective. Ask your doctor about using non hormonal birth control (condom, diaphragm with spermicide) to prevent pregnancy.

You should not breast-feed while you are using VIRACEPT. Women with HIV or AIDS should not breast-feed at all. Even if your baby is born without HIV, you may still pass the virus to the baby in your breast milk.

VIRACEPT is not approved for use by anyone younger than 2 years old.

Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin; or
high blood sugar--increased thirst, increased urination, hunger, dry mouth, fruity breath odor, drowsiness, dry skin, blurred vision, weight loss.

VIRACEPT may increase your risk of certain infections or autoimmune disorders by changing the way your immune system works. Symptoms may occur weeks or months after you start treatment with VIRACEPT. Tell your doctor if you have:

signs of a new infection--fever, night sweats, swollen glands, mouth sores, diarrhea, stomach pain, weight loss;
chest pain (especially when you breathe), dry cough, wheezing, feeling short of breath;
cold sores, sores on your genital or anal area;
rapid heart rate, feeling anxious or irritable, weakness or prickly feeling, problems with balance or eye movement;
trouble speaking or swallowing, severe lower back pain, loss of bladder or bowel control; or
swelling in your neck or throat (enlarged thyroid), menstrual changes, impotence, loss of interest in sex.

Common side effects may include:

infections;
nausea, diarrhea, gas, stomach pain;
loss of appetite;
rash; or
changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and waist).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

If you also take didanosine, take it 1 hour before or 2 hours after you take VIRACEPT.

Taking this medicine will not prevent you from passing HIV to other people. Do not have unprotected sex or share razors or toothbrushes. Talk with your doctor about safe ways to prevent HIV transmission during sex. Sharing drug or medicine needles is never safe, even for a healthy person.

Many drugs can interact with VIRACEPT. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any you start or stop using, especially:

any other antiviral medicines to treat HIV;
bosentan;
carbamazepine;
colchicine;
fluticasone;
methadone;
midazolam injection;
omeprazole;
quetiapine;
salmeterol;
warfarin (Coumadin, Jantoven);
an antibiotic--azithromycin, rifabutin;
cholesterol medication--atorvastatin, rosuvastatin;
medicine to prevent organ transplant rejection--cyclosporine, sirolimus, tacrolimus;
medicine to treat impotence or pulmonary arterial hypertension--avanafil (Stendra), sildenafil (Viagra), tadalafil (Adcirca, Cialis), or vardenafil (Levitra, Staxyn); or
seizure medicine--phenobarbital, phenytoin.

This list is not complete and many other drugs can interact with VIRACEPT. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Give a list of all your medicines to any healthcare provider who treats you.

Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.

Read all patient information, medication guides, and instruction sheets provided to you. Ask your doctor or pharmacist if you have any questions.

VIRACEPT works best if you take it with food.

Swallow the VIRACEPT tablet whole.

If you cannot swallow a whole tablet, dissolve it in a small amount of water. Stir this mixture and drink all of it right away. To make sure you get the entire dose, add a little more water to the same glass, swirl gently and drink right away.

If a child is using this medicine, tell your doctor if the child has any changes in weight. VIRACEPT doses are based on weight in children, and any changes may affect your child's dose.

Use VIRACEPT regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.

HIV/AIDS is usually treated with a combination of drugs. Use all medications as directed by your doctor. Read the medication guide or patient instructions provided with each medication. Do not change your doses or medication schedule without your doctor's advice. Every person with HIV or AIDS should remain under the care of a doctor.

While using VIRACEPT, you may need frequent blood tests.

Store at room temperature away from moisture and heat.

Seek emergency medical attention or call the Poison Help line.

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

Viramune (Nevirapine)

Author Dev, posted on June 16, 2017

Category:

general ill feeling or “flu-like” symptoms
tiredness
nausea (feeling sick to your stomach)
lack of appetite
yellowing skin or whites of your eyes
dark urine (tea colored)
pale stools (bowel movements)
pain, ache, or sensitivity to touch on your right side below your ribs

Skin Reactions:

general ill feeling or “flu-like” symptoms
fever
muscle or joint aches
conjunctivitis (red or inflamed eyes, like “pinkeye”)
blisters
mouth sores
swelling of your face
tiredness
any symptoms of liver problems discussed above

These are not all the side effects of VIRAMUNE or VIRAMUNE XR. Tell your doctor if you have any side effects from VIRAMUNE or VIRAMUNE XR.

BEFORE you use VIRAMUNE or VIRAMUNE XR talk to your doctor or pharmacist:

If you have or have had any diseases of the liver particularly hepatitis B or C infection;
If you are pregnant or intend to become pregnant;
If you are a breast-feeding mother. It is recommended that HIV infected women not breastfeed, to avoid transmission of the virus to the infant;
If you are taking any medications, including prescription, non-prescription, herbal or homeopathic remedies;
If you have any allergies to foods or drugs;
If you are undergoing dialysis.